Interestingly, the C19MChigh group harbored significantly downregulated expression of PGR, ESR1 and ERBB2 mRNAs compared to C19MClow group, the candidate “negative markers” of triple negative breast cancers (Fig 1C–1E)[12, 19]. Here, ERBB2 is linked to triple-negative breast carcinoma.